A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Michael H. Cullen, Petr Zatloukal, S Sörenson et al. · Annals of Oncology · 2008

Cited by 73 works. doi:10.1093/annonc/mdm592

Authors

References